Evidence map›Paper›PMID 38639723›Full record

Trial reportJAMA2024

Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection: The INSPIRE Randomized Clinical Trial.

Shruti K Gohil, Edward Septimus, Ken Kleinman, Neha Varma, Taliser R Avery, Lauren Heim, Risa Rahm, William S Cooper, Mandelin Cooper, Laura E McLean and 30 more

Registry-linked trialOpen access · greenAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03697096 (INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients With Urinary Tract Infections), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03697096 nacompletednot on this map

INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection for Patients With Urinary Tract Infections (UTI)

TypeinterventionalSponsorHarvard Pilgrim Health CareRan2018 to 2024Enrolled55,412ConditionsUrinary Tract Infection (UTI)ArmsRoutine Care, INSPIRE CPOE Smart Prompt
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. The institutional antibiogram: Time for a makeover?Journal of hospital medicine · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A pilot intervention to improve the management of urinary tract infections in outpatient settings.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 11 institutions in 1 country.

Shruti K GohilDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Edward SeptimusDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Ken KleinmanBiostatistics and Epidemiology, University of Massachusetts, Amherst.
Neha VarmaDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Taliser R AveryDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Lauren HeimDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Risa RahmHCA Healthcare, Nashville, Tennessee.
William S CooperHCA Healthcare, Nashville, Tennessee.
Mandelin CooperHCA Healthcare, Nashville, Tennessee.
Laura E McLeanHCA Healthcare, Nashville, Tennessee.
Naoise G NickolayHCA Healthcare, Nashville, Tennessee.
Robert A WeinsteinRush University Medical Center, Cook County Health, Chicago, Illinois.
L Hayley BurgessHCA Healthcare, Nashville, Tennessee.
Micaela H CoadyDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Edward RosenDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Selsebil SljivoDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Kenneth E SandsDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Julia MoodyHCA Healthcare, Nashville, Tennessee.
Justin VigeantDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Syma RashidDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Rebecca F GilbertDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Kim N SmithHCA Healthcare, Nashville, Tennessee.
Brandon CarverHCA Healthcare, Nashville, Tennessee.
Russell E PolandDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Jason HickokHCA Healthcare, Nashville, Tennessee.
S G SturdevantNational Institutes of Health, Bethesda, Maryland.
Michael S CalderwoodSection of Infectious Disease and International Health, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
Anastasiia WeilandDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
David W KubiakBrigham and Women's Hospital, Boston, Massachusetts.
Sujan ReddyCenters for Disease Control and Prevention, Atlanta, Georgia.
Melinda M NeuhauserCenters for Disease Control and Prevention, Atlanta, Georgia.
Arjun SrinivasanCenters for Disease Control and Prevention, Atlanta, Georgia.
John A JerniganCenters for Disease Control and Prevention, Atlanta, Georgia.
Mary K HaydenRush University Medical Center, Chicago, Illinois.
Abinav GowdaDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Katyuska EibensteinerDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Robert WolfDepartment of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
Jonathan B PerlinHCA Healthcare, Nashville, Tennessee.
Richard PlattDepartment of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts.
Susan S HuangDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine.
Harvard Pilgrim Health Care · USHCA Healthcare · USUniversity of California, Irvine · USCenters for Disease Control and Prevention · USHarvard University · USBrigham and Women's Hospital · USCook County Health and Hospitals System · USDartmouth–Hitchcock Medical Center · USNational Institutes of Health · USRush University Medical Center · USUniversity of Massachusetts Amherst · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Urinary tract infection (UTI) is the second most common infection leading to hospitalization and is often associated with gram-negative multidrug-resistant organisms (MDROs). Clinicians overuse extended-spectrum antibiotics although most patients are at low risk for MDRO infection. Safe strategies to limit overuse of empiric antibiotics are needed. Objective: To evaluate whether computerized provider order entry (CPOE) prompts providing patient- and pathogen-specific MDRO risk estimates could reduce use of empiric extended-spectrum antibiotics for treatment of UTI. Design, Setting, and Participants: Cluster-randomized trial in 59 US community hospitals comparing the effect of a CPOE stewardship bundle (education, feedback, and real-time and risk-based CPOE prompts; 29 hospitals) vs routine stewardship (n = 30 hospitals) on antibiotic selection during the first 3 hospital days (empiric period) in noncritically ill adults (≥18 years) hospitalized with UTI with an 18-month baseline (April 1, 2017-September 30, 2018) and 15-month intervention period (April 1, 2019-June 30, 2020). Interventions: CPOE prompts recommending empiric standard-spectrum antibiotics in patients ordered to receive extended-spectrum antibiotics who have low estimated absolute risk (<10%) of MDRO UTI, coupled with feedback and education. Main Outcomes and Measures: The primary outcome was empiric (first 3 days of hospitalization) extended-spectrum antibiotic days of therapy. Secondary outcomes included empiric vancomycin and antipseudomonal days of therapy. Safety outcomes included days to intensive care unit (ICU) transfer and hospital length of stay. Outcomes were assessed using generalized linear mixed-effect models to assess differences between the baseline and intervention periods. Results: Among 127 403 adult patients (71 991 baseline and 55 412 intervention period) admitted with UTI in 59 hospitals, the mean (SD) age was 69.4 (17.9) years, 30.5% were male, and the median Elixhauser Comorbidity Index count was 4 (IQR, 2-5). Compared with routine stewardship, the group using CPOE prompts had a 17.4% (95% CI, 11.2%-23.2%) reduction in empiric extended-spectrum days of therapy (rate ratio, 0.83 [95% CI, 0.77-0.89]; P < .001). The safety outcomes of mean days to ICU transfer (6.6 vs 7.0 days) and hospital length of stay (6.3 vs 6.5 days) did not differ significantly between the routine and intervention groups, respectively. Conclusions and Relevance: Compared with routine stewardship, CPOE prompts providing real-time recommendations for standard-spectrum antibiotics for patients with low MDRO risk coupled with feedback and education significantly reduced empiric extended-spectrum antibiotic use among noncritically ill adults admitted with UTI without changing hospital length of stay or days to ICU transfers. Trial Registration: ClinicalTrials.gov Identifier: NCT03697096.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipMedical Order Entry SystemsUrinary Tract InfectionsAdultAgedAged, 80 and overDrug Resistance, Multiple, BacterialFemaleHospitals, CommunityHumansLength of StayMaleMiddle AgedAnti-Bacterial Agents

Identifiers

PMID38639723
PMCPMC11185978
OpenAlexW4394962399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.